Ilex Medical

Ilex Medical Dividend Coverage

The Dividend Coverage Ratio of Ilex Medical (ILX.TA) as of Oct 27, 2026 is 2.55. In the previous year, Dividend Coverage Ratio was 2.37 — a change of 7.62% (higher).

Dividend Coverage

2.55

YoY

7.62%

Last updated:

Dividend Coverage Ratio of Ilex Medical is 2024 2.55 . Dividend Coverage Ratio of Ilex Medical was 2023 2.37 . It decreases by 7.62% higher compared to the previous year.

The Ilex Medical Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2016
2.77 ILS
Jan 1, 2017
2.49 ILS
Jan 1, 2018
2.61 ILS
Jan 1, 2019
2.41 ILS
Jan 1, 2021
3.29 ILS
Jan 1, 2022
1.70 ILS
Jan 1, 2023
2.37 ILS
Jan 1, 2024
2.55 ILS
The Ilex Medical Dividend Coverage history
YEARDividend CoverageYoY
2.55+7.62%
2.37+39.38%
1.70-48.26%
3.29+36.51%
2.41-7.65%
2.61+4.67%
2.49-9.82%
2.77+131.22%
1.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

Dividend Coverage Ratio of Ilex Medical is 2.55 in 2024.

Dividend Coverage Ratio of Ilex Medical changed from 2.37 to 2.55, representing a 7.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Ilex Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Ilex Medical

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Ilex Medical